Walleye Capital’s Opko Health OPK Stock Holding History

Walleye Capital’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-14,780	Closed	-$18.5K	–	5722
2024 Q2	$18.5K	Buy	+14,780	New	+$19.2K	﹤0.01%	5129
2023 Q4	–	Sell	-25,415	Closed	-$40.7K	–	5358
2023 Q3	$40.7K	Buy	+25,415	New	+$46.3K	﹤0.01%	4245

Other funds holding OPK

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Walleye Capital's OPK Position: Q3 2024 in Review

Walleye Capital sold out of Opko Health (OPK) in Q3 2024, closing a stake of 14,780 shares — an estimated $18.5K sold.

Walleye Capital first reported a position in OPK in Q3 2023 and held it in 2 quarters. The position peaked at $40.7K in Q3 2023. 234 funds tracked by Wall St. Rank hold OPK as of Q3 2024.

Walleye Capital reported no remaining Opko Health position as of Q3 2024 after selling out during the quarter.
Walleye Capital sold 14,780 Opko Health shares in Q3 2024, an estimated $18.5K.
Walleye Capital first reported a position in Opko Health in Q3 2023 and held it in 2 quarters.
Walleye Capital's Opko Health position peaked at $40.7K in Q3 2023.
234 funds tracked by Wall St. Rank held Opko Health as of Q3 2024.

Based on Walleye Capital's 13F filing for Q3 2024, filed 14 Nov 2024.